Sage Therapeutics, Inc. logo

Sage Therapeutics, Inc.

NASDAQ:SAGE

Overview | Financials
Company Name Sage Therapeutics, Inc.
Symbol SAGE
Currency USD
Price 6.31
Market Cap 386,003,523
Dividend Yield 0%
52-week-range 5.64 - 28.26
Industry Biotechnology
Sector Healthcare
CEO Mr. Barry E. Greene
Website https://www.sagerx.com

An error occurred while fetching data.

About Sage Therapeutics, Inc.

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase

Related Stocks

InMode Ltd. logo

InMode Ltd.

INMD

19.41 USD

Twist Bioscience Corporation logo

Twist Bioscience Corporation

TWST

45.4 USD

AtriCure, Inc. logo

AtriCure, Inc.

ATRC

37.45 USD

Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc.

AMPH

48.31 USD

Bright Green Corporation logo

Bright Green Corporation

BGXX

0.068 USD

Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc.

RLAY

6.2 USD

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

4.24 USD

Financials

Numbers are in millions USD

Numbers are in millions USD